Literature DB >> 21557538

Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents.

Yan Lu1, Chien-Ming Li, Zhao Wang, Jianjun Chen, Michael L Mohler, Wei Li, James T Dalton, Duane D Miller.   

Abstract

In a continued effort to improve upon the previously published 4-substituted methoxybenzoyl-aryl-thiazole (SMART) template, we explored chemodiverse "B" rings and "B" to "C" ring linkage. Further, to overcome the poor aqueous solubility of this series of agents, we introduced polar and ionizable hydrophilic groups to obtain water-soluble compounds. For instance, based on in vivo pharmacokinetic (PK) studies, an orally bioavailable phenyl-amino-thiazole (PAT) template was designed and synthesized in which an amino linkage was inserted between "A" and "B" rings of compound 1. The PAT template maintained nanomolar (nM) range potency against cancer cell lines via inhibiting tubulin polymerization and was not susceptible to P-glycoprotein mediated multidrug resistance in vitro, and markedly improved solubility and bioavailability compared with the SMART template (45a-c (PAT) vs 1 (SMART)).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557538      PMCID: PMC4755333          DOI: 10.1021/jm2003427

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

Review 1.  Novel formulations of taxanes: a review. Old wine in a new bottle?

Authors:  K L Hennenfent; R Govindan
Journal:  Ann Oncol       Date:  2005-12-19       Impact factor: 32.976

2.  beta-Tubulin mutations in ovarian cancer using single strand conformation analysis-risk of false positive results from paraffin embedded tissues.

Authors:  Henrik Gréen; Per Rosenberg; Peter Söderkvist; György Horvath; Curt Peterson
Journal:  Cancer Lett       Date:  2005-07-05       Impact factor: 8.679

Review 3.  The multidrug transporter, a double-edged sword.

Authors:  M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

4.  Paclitaxel resistance in cells with reduced beta-tubulin.

Authors:  Yaqing Wang; Fernando Cabral
Journal:  Biochim Biophys Acta       Date:  2005-01-05

5.  Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations.

Authors:  M Monzó; R Rosell; J J Sánchez; J S Lee; A O'Brate; J L González-Larriba; V Alberola; J C Lorenzo; L Núñez; J Y Ro; C Martín
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

6.  Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.

Authors:  Yan Lu; Zhao Wang; Chien-Ming Li; Jianjun Chen; James T Dalton; Wei Li; Duane D Miller
Journal:  Bioorg Med Chem       Date:  2009-12-11       Impact factor: 3.641

7.  A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

Authors:  G J Rustin; G Shreeves; P D Nathan; A Gaya; T S Ganesan; D Wang; J Boxall; L Poupard; D J Chaplin; M R L Stratford; J Balkissoon; M Zweifel
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

8.  New dihydroxy bis(oxazoline) ligands for the palladium-catalyzed asymmetric allylic alkylation: experimental investigations of the origin of the reversal of the enantioselectivity.

Authors:  Hassan Aït-Haddou; Olivier Hoarau; Dimitri Cramailére; Frédéric Pezet; Jean-Claude Daran; Gilbert G A Balavoine
Journal:  Chemistry       Date:  2004-02-06       Impact factor: 5.236

9.  Carbopalladation of nitriles: synthesis of 2,3-diarylindenones and polycyclic aromatic ketones by the Pd-catalyzed annulation of alkynes and bicyclic alkenes by 2-iodoarenenitriles.

Authors:  Alexandre A Pletnev; Qingping Tian; Richard C Larock
Journal:  J Org Chem       Date:  2002-12-27       Impact factor: 4.354

10.  A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.

Authors:  Ann M Mauer; Ezra E W Cohen; Patrick C Ma; Mark F Kozloff; Lee Schwartzberg; Andrew I Coates; Jiang Qian; Anne E Hagey; Gary B Gordon
Journal:  J Thorac Oncol       Date:  2008-06       Impact factor: 15.609

View more
  19 in total

1.  Palladium-catalyzed arylation of cyanamides.

Authors:  Ryan M Stolley; Wenxing Guo; Janis Louie
Journal:  Org Lett       Date:  2011-12-05       Impact factor: 6.005

2.  Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents.

Authors:  Dong-Jin Hwang; Jin Wang; Wei Li; Duane D Miller
Journal:  ACS Med Chem Lett       Date:  2015-08-06       Impact factor: 4.345

3.  Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent.

Authors:  Vaibhav Mundra; Yan Lu; Michael Danquah; Wei Li; Duane D Miller; Ram I Mahato
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

4.  Palladium-catalyzed N-arylation of 2-aminothiazoles.

Authors:  Meredeth A McGowan; Jaclyn L Henderson; Stephen L Buchwald
Journal:  Org Lett       Date:  2012-03-06       Impact factor: 6.005

5.  New substituted 4H-chromenes as anticancer agents.

Authors:  Shivaputra A Patil; Jin Wang; Xiaochen S Li; Jianjun Chen; Terreia S Jones; Amira Hosni-Ahmed; Renukadevi Patil; William L Seibel; Wei Li; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2012-04-24       Impact factor: 2.823

6.  Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.

Authors:  Vaibhav Mundra; Yang Peng; Virender Kumar; Wei Li; Duane D Miller; Ram I Mahato
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

7.  Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.

Authors:  Kinsie E Arnst; Yuxi Wang; Zi-Ning Lei; Dong-Jin Hwang; Gyanendra Kumar; Dejian Ma; Deanna N Parke; Qiang Chen; Jinliang Yang; Stephen W White; Tiffany N Seagroves; Zhe-Sheng Chen; Duane D Miller; Wei Li
Journal:  Mol Pharmacol       Date:  2019-05-01       Impact factor: 4.436

8.  Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole.

Authors:  Andrei A Gakh; Andrey V Sosnov; Mikhail Krasavin; Tam Luong Nguyen; Ernest Hamel
Journal:  Bioorg Med Chem Lett       Date:  2013-01-11       Impact factor: 2.823

9.  Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.

Authors:  Debasish Dutta; Manish Debnath; Diana Müller; Rakesh Paul; Tania Das; Irene Bessi; Harald Schwalbe; Jyotirmayee Dash
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

10.  2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases.

Authors:  Pinhong Chen; Lori B Horton; Rose L Mikulski; Lisheng Deng; Sandeep Sundriyal; Timothy Palzkill; Yongcheng Song
Journal:  Bioorg Med Chem Lett       Date:  2012-08-10       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.